ArticleHematological oncology2022

Network meta-analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant.

Cirino Botta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.